Samuel Riccitelli

Samuel D.
Riccitelli is the Lead Independent Director at OrthoPediatrics Corp.
since 2017.
Former roles include Chairman, President & Chief Executive Officer at Biocept, Inc. from 2022 to 2023; President, Chief Executive Officer & Director at Signal Genetics, Inc. from 2015 to 2017; President & Chief Executive Officer at Viridian Therapeutics, Inc. from 2014 to 2017; Chief Executive Officer at Cap Diagnostics LLC from 2019 to 2020; Chairman at Precipio, Inc. from 2017 to 2019 and also Chairman at Precipio Diagnostics LLC; Director at Transgenomic, Inc.; Director at BD Ventures LLC from 1995 to 2001; Director at Exagen, Inc. from 2011 to 2014; Vice President & General Manager at Becton, Dickinson & Co. from 1995 to 2001; General Manager at Puritan Bennett Corp.
from 1989 to 1994; Chief Operating Officer & Executive Vice President at Genoptix, Inc. from 2001 to 2011.
Education includes a graduate degree from The University of Texas at Austin in 1984 and an undergraduate degree from Washington & Jefferson College in 1981.